FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy. Ruby Khatun Khatun19 Sept 2017 9:24 AM ISTATLANTA and BRUSSELS: UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for...
Mylan launches generic Minastrin® 24 FE tablets in US Ruby Khatun Khatun18 Sept 2017 10:38 AM ISTHERTFORDSHIRE, England, and PITTSBURGH: Mylan N.V. announced the U.S. launch of Norethindrone Acetate and Ethinyl Estradiol Tablets USP, and Ferrous...
GSK three-in-one inhaler gets positive opinion from EU agency Ruby Khatun Khatun18 Sept 2017 10:08 AM ISTGlaxoSmithKline (GSK) said on Friday that a European Medicines Agency (EMA) panel has recommended the company’s three-in-one inhaled lung drug.GSK’s...
Lilly, Incyte pill beats placebo in mid-stage eczema trial Ruby Khatun Khatun18 Sept 2017 9:47 AM ISTEli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better...
US senator slams Allergan patent deal with Native-American tribe Ruby Khatun Khatun18 Sept 2017 9:31 AM ISTUS Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents “rips off consumers”...
Tesaro ovarian cancer drug gets EU agency backing Ruby Khatun Khatun18 Sept 2017 9:15 AM ISTA European Medicines Agency (EMA) panel recommended the approval of Tesaro Inc’s key drug, niraparib, for the treatment of recurrent ovarian...
India, Japan sign MoU for expansion of biotech lab Ruby Khatun Khatun17 Sept 2017 11:01 AM ISTNew Delhi: India and Japan signed a MoU for expansion of an international laboratory set up for a collaborative research in the area of...
Teva to sell womens health assets to CVC Capital Partners: report Ruby Khatun Khatun17 Sept 2017 10:14 AM ISTTeva Pharmaceutical Industries Ltd is close to a deal to sell its women’s health assets outside the United States to private equity firm CVC Capital...
Astrazeneca Farxiga results may open up type 1 diabetes opportunity Ruby Khatun Khatun17 Sept 2017 9:57 AM ISTFRANKFURT: AstraZeneca’s Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up an additional market...
Pfizer, Astellas prostate cancer drug promising in late-stage trial Ruby Khatun Khatun17 Sept 2017 9:35 AM ISTPfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for...
Moderna, AstraZeneca heart drug succeeds early-stage trial Ruby Khatun Khatun17 Sept 2017 9:15 AM ISTBiotech unicorn Moderna Therapeutics said on Thursday its heart drug, developed along with British drugmaker AstraZeneca met the main goal in an...
Aspen to buy remaining AstraZeneca anaesthetic rights for up to 766 million dollar Ruby Khatun Khatun16 Sept 2017 10:17 AM ISTLONDON: AstraZeneca said on Thursday it had agreed to sell the U.S. rights to a portfolio of anaesthetics to South Africa's Aspen Group for up to $766...
